• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Press release

Dignitana AB: Dignitana to address MedTech innovation at Texas BioLife Summit

Dignitana

Dignitana will join MedTech leaders speaking at the Texas BioLife Summit in Dallas on February 27, 2025.

Melissa Bourestom, Dignitana Chief Communications Officer, is featured on a panel titled "Devices and Diagnostics: Where Health and Innovation Meet." The session will focus on the rise of innovation leading to the development of highly impactful medical devices and diagnostic tools that can be used to both identify and combat an array of health problems. Panelists will discuss challenges they've faced and how to overcome them, as well as navigating the regulatory processes.

"Ongoing innovation is crucial to Dignitana's growth strategy and supports our dedication to providing the best possible clinical outcomes. As we work toward establishing scalp cooling as standard of care, we see patient demand driving both innovation and adoption, and we continue to advance on both fronts," said Melissa Bourestom.

Agenda for the day is here: biolifesummits.com/agenda